Form 4: CompoSecure Executive Chairman David Cote Acquires Stock Options
SEC Form 4 Filing
David Cote, Executive Chairman and Co-Chief Investment Officer of CompoSecure, acquired 837,037 stock options on October 1, 2024.
Summary
- David Cote, Executive Chairman and Co-Chief Investment Officer of CompoSecure, filed a Form 4 on October 3, 2024.
- The filing reports a transaction that occurred on October 1, 2024, where Cote acquired 837,037 stock options.
- The exercise price of these options is $13.82.
- The options vest in equal annual installments of 25% each, starting on October 1, 2025, and continuing on the first, second, and third anniversaries thereafter.
- The options expire on October 1, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a key executive is generally viewed as a sign of confidence in the company's future, but it's a routine transaction.
Positives
- The acquisition of stock options by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. The acquisition of stock options is a common form of executive compensation.
Stakeholder Impact
- The acquisition of stock options by a key executive could potentially boost investor confidence.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of stock option acquisition |
| 10/01/2025 | First vesting date of the stock options (25%) |
| 10/01/2034 | Expiration date of the stock options |
| 10/03/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.